Hazard Information | Back Directory | [Uses]
ODN 1018 (1018 ISS), an oligodeoxynucleotide, is a TLR-9 agonist. ODN 1018 is also a synthetic immunostimulatory sequence that can be used as vaccine adjuvant. Sequence: 5′-TGACTGTGAACGTTCGAGATGA-3′[1][2]. | [IC 50]
TLR9 | [References]
[1] Friedberg JW, et al. Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma. Br J Haematol. 2009 Aug;146(3):282-91. DOI:10.1111/j.1365-2141.2009.07773.x [2] Eng NF, et al. The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV? review. Hum Vaccin Immunother. 2013 Aug;9(8):1661-72. DOI:10.4161/hv.24715 |
|
Company Name: |
Apextide Co Ltd Gold
|
Tel: |
15300650552 |
Website: |
www.apextide.com/ |
Company Name: |
Ribobay Gold
|
Tel: |
(86) 0550-5361572 13958538646 |
Website: |
www.ribobay.com/en/ |
Company Name: |
Asymchem Labs. Gold
|
Tel: |
17347534561 |
Website: |
https://www.asymchem.com.cn/ |
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
www.biorbyt.com |
|